Vimarsana
Biggest News Aggregation in the World

Experimental Therapeutics Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Experimental Therapeutics Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Experimental Therapeutics Program Today - Breaking & Trending Today

Aliasger K. Salem - Vimarsana News

Aliasger K. Salem

Published: November 27, 2023

Aliasger K. Salem’s profile on The Conversation

Source: theconversation.com
Related Topics:
United StatesUnited KingdomAliasger SalemAmerican Institute ForProfessor Of Pharmaceutical SciencesLeadership In Research AwardAmerican Association For The Advancement Of ScienceResearch For The University Of IowaAston University Of ScienceAmerican Association For Pharmaceutical ScientistsDepartment Of DefenseAmerican Cancer SocietyHolden Comprehensive Cancer CenterJohns Hopkins School Of MedicineNational Institutes For HealthUniversity Of NottinghamUniversity Of IowaResearch ProgramsEnvironmental Health Sciences Research CenterAssociate Vice PresidentBighley ChairPharmaceutical SciencesAmerican AssociationPharmaceutical ScientistsExperimental Therapeutics Program
Dr Komrokji on Ongoing Investigations With Luspatercept in MDS - Vimarsana News

Dr Komrokji on Ongoing Investigations With Luspatercept in MDS

Published: November 3, 2023

Rami Komrokji, MD, discusses the benefit of agents such as luspatercept-aamt in patients with very low– to intermediate-risk myelodysplastic syndromes who have not received prior treatment with erythropoiesis-stimulating agents.

Source: onclive.com
Related Topics:
University Of South FloridaMoffitt Cancer CenterMedicine Oncologic SciencesMalignant Hematology DepartmentExperimental Therapeutics ProgramCollege Of MedicineRami KomrokjiMalignant HematologyOncologic SciencesSouth FloridaOnclive Tv
Thyroid nodules are common. Here's what to do after you check your neck. - News - Vimarsana News

Thyroid nodules are common. Here's what to do after you check your neck. - News

Published: September 19, 2023

Physicians in the O’Neal Comprehensive Cancer Center at UAB are advancing the field of thyroid care with cutting-edge, patient-specific procedures and collaborative research investigations. Written by: Julie Cole Miller...

Source: uab.edu
Related Topics:
United StatesBrenessa LindemanRenata Jaskula SztulJulie Cole MillerJessica FazendinSuzannee LapiBrianna HogeDepartment Of RadiologyDepartment Of SurgeryAmerican Cancer SocietyOneal Comprehensive Cancer CenterExperimental Therapeutics ProgramJulie ColeO Neal Comprehensive Cancer CenterO Neal Comprehensive CancerHealth CareEconomic Development
Dr Komrokji on the Potential Implications of the COMMANDS trial in MDS - Vimarsana News

Dr Komrokji on the Potential Implications of the COMMANDS trial in MDS

Published: July 20, 2023

Rami Komrokji, MD, shares the potential clinical implications of data from the phase 3 COMMANDS trial of luspatercept in patients with very low– to intermediate-risk myelodysplastic syndromes who have not received prior treatment with an erythropoiesis-stimulating agents.

Source: onclive.com
Related Topics:
Medicine Oncologic SciencesMoffitt Cancer CenterExperimental Therapeutics ProgramUniversity Of South FloridaMalignant Hematology DepartmentCollege Of MedicineRami KomrokjiMalignant HematologyOncologic SciencesSouth FloridaOnclive TvMyeloproliferative NeoplasmsMyelodysplastic Syndromes
Dr Kilburn on Findings From the FIREFLY-1 Trial of Tovorafenib in Pediatric Low-Grade Glioma - Vimarsana News

Dr Kilburn on Findings From the FIREFLY-1 Trial of Tovorafenib in Pediatric Low-Grade Glioma

Published: July 10, 2023

Lindsay Kilburn, MD, discusses key efficacy findings from the phase 2 FIREFLY-1 trial of the investigational type II RAF inhibitor tovorafenib (DAY101) in heavily pretreated pediatric patients with low-grade glioma.

Source: onclive.com
Related Topics:
Lindsay KilburnBrain Tumor InstituteChildren National HospitalExperimental Therapeutics ProgramBlood DisordersNational HospitalOvorafenib Day101 2023 Asco Annual MeetingPhase 2 Firefly Trial Phase 2 Firefly 1 TrialPediatric Low Grade Glioma